Dosimetry audit for a multi-centre IMRT head and neck trial

Radiotherapy and Oncology

Volumn 93, Issue 1, 2009, Pages 102-108

  Clark, Catharine H ^a   Hansen, Vibeke Nordmark ^a   Chantler, Hannah ^b   Edwards, Craig ^c   James, Hayley V ^d   Webster, Gareth ^e   Miles, Elizabeth A ^a   Guerrero Urbano, M Teresa ^a   Bhide, Shree A ^a   Bidmead, A Margaret ^a   Nutting, Christoper M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d IPSWICH HOSPITAL   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Dosimetry; IMRT; Phase III trial; Quality assurance

Indexed keywords

ACCREDITATION; ARTICLE; CLINICAL TRIAL; DOSIMETRY; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT PLANNING; UNITED KINGDOM;

AGED; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; QUALITY CONTROL; RADIATION TOLERANCE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; TREATMENT OUTCOME;

EID: 70349326448     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.04.025     Document Type: Article

References (27)

1. Mornex F., Pavy J.J., Denekamp J., and Bolla M. Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale. Cancer Radiother 1 (1997) 622-668
2. Clark C.H., Miles E.A., Guerrero Urbano M.T., Bhide S.A., Bidmead A.M., Harrington K.J., et al. Pre-trial quality assurance processes for an IMRT trial: PARSPORT, a UK multi-centre phase III trial comparing conventional radiotherapy and parotid sparing IMRT for locally advanced head and neck cancer. Br J Radiol 82 (2009) 585-594
3. PARSPORT Protocol. A multi-centre randomised study of parotid sparing intensity modulated radiotherapy versus conventional radiotherapy in patients with head and neck cancer. ISRCTN: 48243537 2003.
4. Purdy J.A. Quality assurance issues in conducting multi-institutional advanced technology clinical trials. Int J Radiat Oncol Biol Phys 71 (2008) s66-s70
5. Leif J., Roll J., Followill D.S., and Ibbott G.S. The value of credentialing. Int J Radiat Oncol Biol Phys 66 (2006) S716
6. Venables K., Winfield E., Deighton A., Aird E., and Hoskin P. The START trial-measurements in semi-anatomical breast and chest wall phantoms. Phys Med Biol 46 (2001) 1937-1948
7. Aird E.G.A., Williams C., Mott G.T.M., Dische S., and Saunders M.I. Quality assurance in the CHART clinical trial. Radiother Oncol 36 (1995) 235-245
8. Poortmans P.M., Davis J.B., Ataman F., Bernier J., Horiot J.-.C., and Group ftER. The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future. EJSO J Cancer Surg 31 (2005) 667-674
9. Pettersen M., Aird E., and Olsen D. Quality assurance of dosimetry and the impact on sample size in randomized clinical trials. Radiother Oncol 86 (2008) 195-199
10. Radiotherapy Trials Quality Assurance Group. Available from: http://rttrialsqa.org.uk/.
11. Van Esch A., Bohsung J., Sorvari P., Tenhunen M., Paiusco M., Iori M., et al. Acceptance tests and quality control (QC) procedures for the clinical implementation of intensity modulated radiotherapy (IMRT) using inverse planning and the sliding window technique: experience from five radiotherapy departments. Radiother Oncol 65 (2002) 53-70
12. ICRU Report 44, Appendix A.
13. Low D.A., Harms W.B., Mutic S., and Purdy J.A. A technique for the quantitative evaluation of dose distributions. Med Phys 25 (1998) 656-661
14. Depuydt T., Van Esch A., and Huyskens D. A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation. Radiother Oncol 62 (2002) 309-319
15. Gillis S., De Wagter C., Bohsung J., Perrin B.A., Williams P., and Mijnheer B.J. An inter-centre quality assurance network for IMRT verification: Results of the ESTRO QUASIMODO project. Radiother Oncol 76 (2005) 340-353
16. Budgell G.J., Perrin B.A., Mott J.H., Fairfoul J., and Mackay R.I. Quantitative analysis of patient-specific dosimetric IMRT verification. Phys Med Biol 50 (2005) 103-119
17. Zefkili S., Tomsej M., Aletti P., Bidault F., Bridier A., Marchesi V., et al. Recommendations for a head and neck IMRT quality assurance protocol. Cancer/Radiotherapie 8 (2004) 364-379
18. De Martin E., Fiorino C., Broggi S., Longobardi B., Pierelli A., Lucia Perna L., et al. Agreement criteria between expected and measured field fluences in IMRT of head and neck cancer: the importance and use of the gamma histograms statistical analysis. Radiother Oncol 85 (2007) 399-406
19. van Zijtveld M., Dirkx M., de Boer H., and Heijmen B. Dosimetric pre-treatment verification of IMRT using an EPID; clinical experience. Radiother Oncol 81 (2006) 168-175
20. Molineu A., Followill D.S., Balter P.A., Hanson W.F., Gillin M.T., Huq M.S., et al. Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 63 (2005) 577-583
21. Ibbott G.S., Molineu A., and Followill D.S. Independent evaluations of IMRT through the use of an anthropomorphic phantom. Technol Cancer Res Treat 5 (2006) 481-487
22. Moore A.R., Stanley S., Bidmead A.M., Dearnaley D.P., Mayles W.P.M., Warrington A.P., et al. Quality assurance of dosimetry in UK MRC RT01 prostate dose escalation conformal radiotherapy trial (ISRCTN 47772397). Clin Oncol 15 (2003) 8
23. Clark C.H., Chantler H., Edwards C., Hansen V.N., James H., Webster G., et al. How well can UK centres deliver head and neck IMRT? A dosimetry audit for the PARSPORT trial. Radiother Oncol 88 (2008) S26
24. CHHiP protocol. Conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. ISRCTN: 97182923 2005. Available from: http://rttrialsqa.org.uk/.
25. IMPORT high protocol. Intensity modulated and partial organ radiotherapy. Randomised trial testing dose escalated intensity modulated radiotherapy for women treated by breast conservation surgery and appropriate systemic therapy for early breast cancer. ISRCTN: 47437448 2008 Available from: http://rttrialsqa.org.uk/.
26. COSTAR protocol. Cochlear sparing therapy and conventional radiation. ISRCTN: 81772291 2008. Available from: http://rttrialsqa.org.uk/.
27. James H, Beavis A, Budgell GJ, Clark CH, Convery DJ, Mott JH. Guidance for the clinical implementation of intensity modulated radiation therapy. Institute of Physics and Engineering in Medicine. Report no 96; 2008.